Pharmaceutical

Hotspur Technologies, Inc. announced today that it has received FDA clearance for the first three commercial products in its portfolio. These products are based on Hotspur's unique and groundbreaking technology that makes dialysis access ...

As of July 30, 2010, the share capital in Diamyd Medical AB is 14,530,138.50 SEK. The total number of votes is 4,200,116 and the total number of shares is 29,060,277, divided among 1,437,876 shares of series A and 27,622,401 shares of series B .

Number of shares and votes in Active Biotech

Data on Basilea's Toctino(R) in daily medical practice in Germany presented at dermatology congress

Pacgen Biopharmaceuticals Corporation reported financial results from its fiscal year ended March 31, 2010 . Unless specified otherwise, amounts are expressed in Canadian dollars and in accordance with Canadian Generally Accepted Accounting ...

Pacgen Biopharmaceuticals Corporation reported financial results from its fiscal year ended March 31, 2010 . Unless specified otherwise, amounts are expressed in Canadian dollars and in accordance with Canadian Generally Accepted Accounting ...

Bradmer Completes Previously Announced Private Placement

WuXi PharmaTech Inc. announced today that its previously announced transaction with Charles River Laboratories International Inc. has been terminated by mutual agreement due to Charles River shareholder opposition. Under the terms of the ...